JAK2 and Thrombocytosis: In addition to ET and PMF patients, CALR mutations have also been observed in 3(13.0%) of 24 patients with refractory anemia with ringed sideroblasts and marked thrombocytosis; none of the 3 patients had JAK2 or MPL mutations [9].